RHÖN-KLINIKUM AG / Key word(s): AGM/EGM13.06.2012 / 16:59
Results for financial year 2011- 11.5 % increase in patient treatments is once again proof of the trust inthe high quality of medical services- Growth in revenues and earnings despite tougher framework conditionsdemonstrate sustainability of growth course- Net consolidated profit, EBITDA, EBIT and operating cash flow at recordlevel- Dividend rises according to proposal of Board of Management andSupervisory Board by 22 % to 0.45 EUR per non-par shareQ1 2012 results- Rise in patient numbers by 5.2 % to a total of 609,896 cases underscoresour good start into the new financial year- Revenues climb 5.4 % to reach EUR 682.3 million- Net consolidated declines by 10.3 % to EUR 34.1 million Record figures in 2011 - Growth despite difficult framework conditions'Last year, RHÖN-KLINIKUM AG again broke records and confirmed its growthcourse. This result was achieved despite the legislated cuts in healthcarespending that entered into force at the beginning of 2011 and confirms theCompany's growth course', said the chairman of the Board of Management ofRHÖN-KLINIKUM AG, Wolfgang Pföhler, on Wednesday at the Annual GeneralMeeting of the Company in Frankfurt.The path taken for the development of the Company from classic operator ofhospitals to an integrated healthcare provider had once again proven to bethe right growth path for the Company. During the year 2011 also, thehospitals within the network of RHÖN-KLINIKUM AG had demonstrated that evenamid a difficult environment they can raise service volumes and realiseefficiency reserves to meet their earnings targets.In the first quarter of 2012, the positive growth trend continued. BetweenJanuary and March a total of 609,896 patients were treated at the Group'sfacilities, 5.2 per cent more than in the same period last year. Revenuestotalled 682.3 million EUR, a rise of 5.4 per cent compared with the firstquarter of 2011.Despite the higher patient numbers, net consolidated profit showed a slightdecline compared with the previous year and stands at 34.1 million EUR.This slight decline comes chiefly as a result of demands on the part of thehealth insurance funds regarding the remuneration discount on surplusvolumes to be agreed as well as the discounts of 65 per cent for servicevolumes exceeding that. Besides the issue of surplus service volumes, thequarterly result was burdened by additional costs in the personnel area anddelays in payment for the medical faculties of the university hospitals ofGießen and Marburg.According to Pföhler, the result of financial year 2012 was particularlyaffected by the acquisition of Dr. Horst Schmidt Kliniken (HSK) inWiesbaden. The result would be diluted by the assumption of the currentlosses by an amount in the low double-digit range at HSK, which wasincluded in the group of consolidated companies as at 30 April 2012. Inaddition, it was already foreseeable today that the takeover offer byFresenius, regardless of the outcome, would have an impact on the Company'sperformance. Firstly, in this special situation there was additionalexpenditure for consultancy fees. Secondly, the uncertainty that thispotential transaction is creating was having a noticeable effect on theday-to-day business. However, these effects could not be preciselyquantified at the present time. It was therefore premature to speak ofpossible consequences for the full-year forecast.This year, too, Pföhler expects demand for hospital services to rise. Thatsaid, he urged the regulator to come up with solutions for the futurebecause growth in service volumes and efficiency were being penalised bydiscounts - and that generally and regardless of the causes. Despite thehospital financing measures that were currently the subject of politicaldebate, there was still no solution to the fundamental problem of howrising demand for medical services should be financed in future. Given thesurpluses within the system of statutory health insurance, Pföhleremphasised that not only did the question of the correct distribution ofthe money have to be raised but that new ways of financing the system ofstatutory health insurance also had to be discussed. Higher burdens andoverregulation would have a permanent adverse impact on the healthcareindustry which already today was one of Germany's largest employers.Besides giving some examples of medical excellence among the Group'sfacilities, Pföhler also addressed the subject of Gießen and MarburgUniversity Hospital (UKGM). Pföhler underscored that the public debatecurrently being witnessed obscured the view of the positive facts. At thebiggest employer of Central Hesse, more persons were employed than at thetime of the privatisation. The investment commitments were being made goodon and since 2006 had exceeded the amount of 367 million EUR. With thecompletion of the modern new buildings early 2011 in Gießen, the Companyhad once again demonstrated its expertise. Pföhler called on all thoseinvolved to pursue 'a joint strategy for a successful future of UKGM.' 'Wemust engage in a dialogue with one another constructively. In this regardwe will not always share the same opinion and will arrive at a solution byway of compromise. This compromise then also has to be accepted by allsides.'RHÖN-KLINIKUM AG is one of the largest healthcare providers in Germany. Itscorporate objective is high-quality medical care for everyone. Currently,our Group counts 54 hospitals at 43 sites as well as 39 medical carecentres (MVZs) throughout Germany. We employ about 43,000 persons. Infinancial year 2011, more than 2.2 million patients were treated in theGroup's facilities. Further information is available at:www.rhoen-klinikum-ag.comMax Müller Head of Corporate CommunicationsFriedrichstraße 82D-10117 BerlinPhone: +49 30 20603-700Fax: +49 30 20603-70Email: max.mueller@rhoen-klinikum-ag.comDr. Kai G. KlingerHead of Investor RelationsSchlossplatz 1D-97616 Bad Neustadt a. d. SaalePhone: +49 9771 65-1318Fax: +49 9771 99-17 36Email: kai.klinger@rhoen-klinikum-ag.comEnd of Corporate News
13.06.2012 Dissemination of a Corporate News, transmitted by DGAP - acompany of EquityStory AG.The issuer is solely responsible for the content of this announcement.DGAP's Distribution Services include Regulatory Announcements,Financial/Corporate News and Press Releases.Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English Company: RHÖN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a.d.Saale Germany Phone: +49 (0)9771 - 65-0 Fax: +49 (0)9771 - 97 467 E-mail: rka@rhoen-klinikum-ag.com Internet: www.rhoen-klinikum-ag.com ISIN: DE0007042301 WKN: 704230 Indices: MDAX Listed: Regulierter Markt in Frankfurt (Prime Standard), München; Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart End of News DGAP News-Service 
 173890 13.06.2012